Omnitek Partners vs. Bionic Power: Exoskeleton Patent Dispute Ends in Dismissal
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | Omnitek Partners, LLC v. Bionic Power, Inc. |
| Case Number | 2:24-cv-00041 |
| Court | Eastern District of Texas, Marshall Division |
| Duration | Jan 2024 – Aug 2024 191 days |
| Outcome | Dismissed with Prejudice |
| Patents at Issue | |
| Accused Products | Bionic Power’s Amplify augmented exoskeleton |
Case Overview
The Parties
⚖️ Plaintiff
A patent assertion entity (PAE) with a portfolio targeting technology licensees across multiple sectors.
🛡️ Defendant
A Canadian-based company developing energy-harvesting and augmented exoskeleton technologies for military, industrial, and rehabilitation markets.
Patents at Issue
This case involved two U.S. patents central to biomechanical energy harvesting and exoskeletal technology. These patents sit at the intersection of biomedical engineering and wearable device patent law.
- • US 7,645,246 B2 — Directed to biomechanical energy harvesting systems.
- • US 8,062,237 B2 — Covers further developments in orthopedic and exoskeletal energy-capture technology.
Designing a similar exoskeleton product?
Check if your exoskeleton design might infringe these or related patents before launch.
The Verdict & Legal Analysis
Outcome
The case was dismissed with prejudice pursuant to Federal Rules of Civil Procedure 41(a)(1)(A)(ii) and 41(a)(1)(B), following a joint stipulation by both parties. This outcome signals a mutual agreement to end the litigation permanently, with each party bearing its own costs and fees. The specific financial terms were not publicly disclosed.
Key Legal Issues
The case terminated before any claim construction ruling or substantive motion practice. This means no judicial interpretation of the patent claims exists in the public record, leaving the underlying IP landscape somewhat unsettled for third parties. The absence of an IPR filing by Bionic Power is strategically notable, suggesting an elected settlement path over USPTO validity challenges.
Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in exoskeleton design. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation.
- View all related patents in the exoskeleton technology space
- See which companies are most active in wearable tech patents
- Understand patent assertion entity (PAE) strategies
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own technology or product.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
Biomechanical energy harvesting systems
Dismissed with Prejudice
Case resolved without full adjudication
2 Patents Asserted
Key patents for exoskeleton design
✅ Key Takeaways
E.D. Texas / Judge Gilstrap remains a dominant venue for wearable technology patent assertions.
Explore E.D. Texas litigation trends →Dismissal with prejudice and mutual fee-bearing often indicate a confidential settlement structure.
Analyze settlement patterns →No claim construction record limits precedential utility but preserves assertion value for similar targets.
Search similar cases →Exoskeleton product teams should document design decisions and prior art reliance to support IPR readiness.
Start IPR readiness analysis →Energy-harvesting biomechanical systems face patent risk from PAE portfolios — early clearance opinions are advisable.
Run FTO analysis for my product →Consider IPR petitions as parallel-track leverage tools, even if settlement is likely, to shift licensing dynamics.
Explore PTAB analytics →Frequently Asked Questions
Two patents were asserted: U.S. Patent No. 7,645,246 B2 and U.S. Patent No. 8,062,237 B2, both covering biomechanical energy harvesting and exoskeletal technology.
The parties filed a Joint Stipulation of Dismissal under FRCP 41(a)(1)(A)(ii), indicating a mutual agreement to end the litigation permanently. Financial terms were not publicly disclosed, but it signifies a resolution between the parties.
It confirms active PAE assertion activity in the wearable tech space and signals that early settlement before claim construction remains a viable resolution path in E.D. Texas. Companies developing similar products should conduct proactive FTO analysis.
Ready to Strengthen Your Patent Strategy?
Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.
PatSnap IP Intelligence Team
Patent Research & Competitive Intelligence · PatSnap
This analysis was produced by the PatSnap IP Intelligence Team — a group of patent analysts, IP strategists, and data scientists who work daily with PatSnap’s global patent database of over 2 billion structured data points across patents, litigation records, scientific literature, and regulatory filings.
The team specialises in tracking landmark litigation outcomes, translating complex court rulings into actionable IP strategy, and identifying the competitive intelligence implications for R&D and legal teams. All case analysis is grounded in primary sources: official court records, USPTO filings, and Federal Circuit opinions.
References
- PACER Case 2:24-cv-00041
- USPTO Patent Search — US7,645,246 B2
- USPTO Patent Search — US8,062,237 B2
- PatSnap — IP Intelligence Solutions for Law Firms
This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.
📑 Table of Contents
🚀 PatSnap Eureka IP Tools
🔍Novelty Search
Find prior art instantly
Patent Drafting
AI-assisted claim writing
FTO Analysis
Assess infringement risk
Concerned About Your Exoskeleton Product?
Don’t wait for litigation. Check your product’s freedom to operate now with AI-powered analysis.
Run FTO for My Product